Prognostic Significance of Endogenous Erythropoietin in Long-Term Outcome of Patients with Acute Decompensated Heart Failure
Toshiyuki Nagai(Hokkaido University), Toshihisa Anzai(Hokkaido University), Tomonori Okamura(Keio University), Satoshi Yasuda(Tohoku University), Takeshi Aiba(National Cerebral and Cardiovascular Center), Yoko Nishida(Foundation for Biomedical Research), Hisao Ogawa(Kumamoto University Hospital), Shoji Kawakami(National Cerebral and Cardiovascular Center), Satoshi Honda(National Cerebral and Cardiovascular Center), Tomoaki Kanaya(United Cerebral Palsy), Takehiro Honma(National Cerebral and Cardiovascular Center), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Aya Higashiyama(Hyogo Medical University), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Atsushi Okada(National Cerebral and Cardiovascular Center), Kengo Kusano(Northwestern University), Michikazu Nakai(National Cerebral and Cardiovascular Center), Naotsugu Iwakami(Kyoto University), Yasuo Sugano(keiyu Hospital), Yoshimi Kubota(Foundation for Biomedical Research), Daisuke Sugiyama(University of Zurich)
Cited by 44
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Cardiovascular Disease and Risk Factors in Asia
|Circulation|2008|916